Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for high rate offunctional cure: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. The company believes that by reducing hepatitis B surface antigen and restoring adaptive immunity a functional cure could be achieved for patients.

Biotechnology

Health Care

Bluejay Therapeutics

Bluejay Therapeutics' headquarters in San Francisco, CA, United States

Jeff Zablocki

Dmitry Koltun

This department focuses on overseeing drug development processes, ensuring clinical trials are conducted efficiently and in compliance with regulations.

Clinical Development

This department oversees and advises on matters related to board operations and corporate governance.

Board Governance

This department oversees the strategic direction and management of the organization.

Executive Leadership

This department focuses on managing investment portfolios and strategies to maximize returns.

Investment Management

This department oversees the planning, execution, and successful completion of projects within the organization.

Program Management

This department focuses on research and development in biochemistry and chemistry, driving innovation and scientific advancements.

Bluejay Therapeutics

Org chart

Teams

Clinical Development

Board Governance

Executive Leadership

Investment Management

Program Management

Biochemistry and Chemistry

Offices

Bluejay Therapeutics

Org chart

Teams

Clinical Development

Board Governance

Executive Leadership

Investment Management

Program Management

Biochemistry and Chemistry

Offices

Related companies